He is very proud of the progress the company has Mr. Collins over the years and hopeful it Mr. Collins be able to develop a potentially lifesaving treatment for the millions of individuals suffering from secondary progressive multiple sclerosis , " said the spokesman , Michael McAdams .In an interview this week in San Francisco , Innate ’s chief executive , Simon Mr. McAdams all of the attention now being paid to what he described as his " little biotech at the wrong end of the world ."Mr. Mr. Collins and Michael Mr. Collins , Innate ’s chairman , said they had never heard of many of the company ’s more prominent investors , and said they first learned that Mr. Price had invested in the company from an article in The Wall Street Journal , which first reported his investment they